Kynmobi Interactions
There are 598 drugs known to interact with Kynmobi (apomorphine), along with 10 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 202 are major, 394 are moderate, and 2 are minor.
- View all 598 medications that may interact with Kynmobi
- View Kynmobi alcohol/food interactions (1)
- View Kynmobi disease interactions (10)
Most frequently checked interactions
View interaction reports for Kynmobi (apomorphine) and the medicines listed below.
- acetaminophen
- Acidophilus Probiotic Blend (lactobacillus acidophilus)
- ACT Fluoride Rinse (fluoride topical)
- Advair HFA (fluticasone / salmeterol)
- Alcohol (contained in alcoholic beverages) (ethanol)
- alpha-lipoic acid
- Alvesco (ciclesonide)
- amantadine
- carbidopa / levodopa
- clonazepam
- donepezil
- duloxetine
- Flomax (tamsulosin)
- gabapentin
- Gocovri (amantadine)
- Horizant (gabapentin enacarbil)
- Inbrija (levodopa)
- melatonin
- mirtazapine
- Myrbetriq (mirabegron)
- Neupro (rotigotine)
- pramipexole
- rivastigmine
- rosuvastatin
- Rytary (carbidopa / levodopa)
- Sinemet (carbidopa / levodopa)
- tadalafil
- trazodone
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
Kynmobi alcohol/food interactions
There is 1 alcohol/food interaction with Kynmobi (apomorphine).
Kynmobi disease interactions
There are 10 disease interactions with Kynmobi (apomorphine) which include:
- alcoholism
- asthma
- cardiovascular/cerebrovascular disease
- dyskinesia
- hypersomnia
- liver disease
- QT prolongation
- renal dysfunction
- hypotension
- psychosis
Report options
QR code containing a link to this page
More about Kynmobi (apomorphine)
- Kynmobi consumer information
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: dopaminergic antiparkinsonism agents
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
